Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

On Friday, former FDA Commissioner and current Pfizer board member Dr. Scott Gottlieb appeared on CNBC’s “Squawk Pod” to discuss COVID-19 and the latest variant, a sub-variant of Omicron.

When asked what Americans should know about the latest variant, Gottlieb said that there are three questions. First, “is it more contagious?”

 

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

U.S.–Iran Nuclear Talks Resume as Moment of Truth Nears in the Middle East

After weeks of uncertainty, the United States and Iran are once…
Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent

U.S. and Iran Resume High-Stakes Nuclear Talks in Oman Amid Rising Regional Tensions

The United States and Iran resumed nuclear negotiations…
Former FDA Head: Immunity From Omicron Likely ‘Protective Against’ New Variant; ‘Doesn’t Appear To Be’ More Virulent